656 ELI-002 immunotherapy induces broad polyfunctional T cell responses in subjects with high relapse risk KRAS mutated pancreatic ductal adenocarcinoma and colorectal cancer

• Christopher M Haqq,
• James R Perry,
• Lochana M Seenappa,
• Haley VanWyk,
• Amy M Tavares,
• Esther Welkowsky,
• Peter C DeMuth,
• Lisa K McNeil

Affiliations

Christopher M Haqq

1Elicio Therapeutics Inc., Boston, MA, USA

James R Perry

1Elicio Therapeutics Inc., Boston, MA, USA

Lochana M Seenappa

1Elicio Therapeutics Inc., Boston, MA, USA

Haley VanWyk

1Elicio Therapeutics Inc., Boston, MA, USA

Amy M Tavares

2Elicio Therapeutics, Fairhaven, MA, USA

Esther Welkowsky

1Elicio Therapeutics Inc., Boston, MA, USA

Peter C DeMuth

1Elicio Therapeutics Inc., Boston, MA, USA

Lisa K McNeil

1Elicio Therapeutics Inc., Boston, MA, USA